Dual Immunotherapy Plus Chemotherapy Benefits Specific Subset of Patients with Lung Cancer
Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor genes were...
9-Oct-2024 9:00 AM EDT
Add to Favorites